Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trulieve CannabisFRA:T0A -5.27%65 ROC (Joel Greenblatt) % is 14.84% as of Mar. 2026, which is 28% below its 10-year median of 20.54. GuruFocus rates FRA:T0A with a GF Score™ of 65/100 and a GF Value™ of €4.78 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 982 Drug Manufacturers companies, Trulieve Cannabis ranks better than 56.62% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Trulieve Cannabis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.84%.
The historical rank and industry rank for Trulieve Cannabis's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:T0A'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -19.07 Med: 20.54 Max: 71.62
Current: 14.67
During the past 10 years, Trulieve Cannabis's highest ROC (Joel Greenblatt) % was 71.62%. The lowest was -19.07%. And the median was 20.54%.
FRA:T0A's ROC (Joel Greenblatt) % is ranked better than 56.62% of 982
companies
in the Drug Manufacturers industry
Industry Median: 11.28
vs FRA:T0A: 14.67
Trulieve Cannabis's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Trulieve Cannabis ROC (Joel Greenblatt) % Related Terms
Trulieve Cannabis ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:T0A vs ANIP, XERS, HROW: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 14.84% mean?
Trulieve Cannabis (FRA:T0A) has a ROC (Joel Greenblatt) % of 14.84% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Trulieve Cannabis and its competitors. This is 28% below median its historical median of 20.54. According to the industry distribution chart, Trulieve Cannabis ranks #426 out of 982 companies in the Drug Manufacturers industry, placing it in the top 43.4%.
Is Trulieve Cannabis' ROC (Joel Greenblatt) % too high?
Trulieve Cannabis' current ROC (Joel Greenblatt) % of 14.84% is 28% below median its 10-year median of 20.54. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.28. Trulieve Cannabis' value of 14.84% is 31.6% above this industry median. Based on the distribution chart, Trulieve Cannabis ranks #426 out of 982 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Trulieve Cannabis has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' ROC (Joel Greenblatt) % compare to ANIP and XERS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #426 out of 982 companies for ROC (Joel Greenblatt) %. This puts Trulieve Cannabis in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 11.28. Trulieve Cannabis' value of 14.84% is 31.6% above this benchmark. While the company's 10-year median is 20.54 vs. the industry median of 11.28, Trulieve Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.28, based on 982 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current ROC (Joel Greenblatt) % of 14.84% is 31.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current ROC (Joel Greenblatt) % is 14.84%, which is 28% below median its own 10-year median of 20.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (FRA:T0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.78, compared to a current price of €7.19 — trading 50.4% above its estimated fair value. The current ROC (Joel Greenblatt) % is 14.84%, which is 28% below median its 10-year median of 20.54 and 31.6% above the Drug Manufacturers industry median of 11.28. Trulieve Cannabis' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Trulieve Cannabis (FRA:T0A), the current ROC (Joel Greenblatt) % is 14.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (FRA:T0A) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of €7.19 is trading 50.4% above its estimated GF Value™ of €4.78.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for FRA:T0A:
ROC (Joel Greenblatt) %: 14.84% (28% below median its 10-year median of 20.54)
GF Value™: €4.78 vs. price of €7.19 (50.4% above fair value)
Industry Position: 31.6% above the Drug Manufacturers median (#426 of 982)
No single metric tells the full story. See the FRA:T0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
65GF Score
Get the complete analysis for FRA:T0A
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:T0A has been successfully added to your 
